The OxERA device arose as a by-product of our BiPAP prototype system and has now evolved into a separate stand-alone device that has proven remarkably effective at treating COVID-19 pneumonia. We have found that the overwhelming need of COVID-19 pneumonia patients is oxygen. In very sick patients, this typically needs to be 100%O2. The differences […]
Author Archives: UMOYA
Breathe in, hold, breathe out… A simple, subconscious action that our very lives depend on entirely, at times taken for granted in its subtlety. Air, the breath of life, comprised of 21%-part Oxygen, 78%-part Nitrogen, and tiny amounts of other gases like Argon, Methane, and Carbon Dioxide. The very anatomical and physiological nature of breathing […]
A smaller portable unit to supply a single patient with room air based BiPAP is also under development. This is in contrast to the manifold feed system which was conceived initially. Oxygen supplementation to each patient is via an individual oxygen supply flow valve and meter at the patient’s station, allowing independent oxygen flow rate […]
Quick update on progress – the Umoya teams solutions for a non-invasive ventilator and alternative air supply are through to the next round of evaluation as part of the governments NVP programme mentioned by Cyril Ramaphosa last week. This has only been possible through the hard work and time commitments of some incredible individuals and […]
Submission of Beta design to the Department of Technology, Innovation and Competition as part of the SA governments call for proposals.
Peer review of Beta by various clinicians and switch to manometer/blower based solution instead of blender/regulator solution.
Reciprocal valve tested with the correct fittings.
Modifications and multiple versions to come up with a final alpha concept for a reciprocal valve.
Availability of respiratory support for the World to assist with COVID-19 treatment.
We are Addressing a Unique Challenge to South Africa Our vision is to address the constraint in the South African Health care system that may result in significant deaths from COVID-19 – the limited ICU capacity and importantly the shortage of the skills required for ICU care.